Singapore Institute of Advanced Medicine Q1 FY27 loss after tax narrows 10% to S$ 5.83 million

• Singapore Institute of Advanced Medicine Holdings narrowed its Q1 FY27 loss after tax 10% year-over-year to S$ 5.83 million.
• Revenue rose 10% year-over-year to S$ 4.51 million, while radiation therapy and medical oncology revenue climbed 89% to S$ 1.3 million.
• Net cash used in operating activities increased year-over-year to S$ 4.93 million.
• The group secured extensions until December 31, 2027, for shareholder loans with aggregate principal amounts of up to S$ 22 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Singapore Institute Of Advanced Medicine Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: LMLOXFHGWCZRD26J) on November 08, 2026, and is solely responsible for the information contained therein.